Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries.

NIHR Global Health Unit on Global Surgery, COVIDSurg Collaborative

On-microscope staging of live cells reveals changes in the dynamics of transcriptional bursting during differentiation.

Jeziorska DM, Tunnacliffe EAJ, Brown JM, Ayyub H, Sloane-Stanley J, Sharpe JA, Lagerholm BC, Babbs C, Smith AJH, Buckle VJ, Higgs DR

Putting prospection into practice: Methodological considerations in the use of episodic future thinking to reduce delay discounting and maladaptive health behaviors.

Brown JM, Stein JS

Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis.

Zheng B, Daines L, Han Q, Hurst JR, Pfeffer P, Shankar-Hari M, Elneima O, Walker S, Brown JS, Siddiqui S, Quint JK, Brightling CE, Evans RA, Wain LV, Heaney LG, Sheikh A

Impact of Glabellar Injection Technique With DaxibotulinumtoxinA for Injection on Brow Position.

Bertucci V, Green JB, Fezza JP, Brown J, Gallagher CJ

Integrative Assessment for Optimizing Aesthetic Outcomes When Treating Glabellar Lines With Botulinum Toxin Type A: An Appreciation of the Role of the Frontalis.

Bertucci V, Carruthers JD, Sherman DD, Gallagher CJ, Brown J

Recruiting to surgical trials in the emergency setting: using a mixed methods study to understand clinician and patient perspectives.

Twiddy M, Birtwistle J, Edmondson A, Croft J, Gordon K, Meads D, Burke D, Griffiths B, Rose A, Sagar P, Stocken D, Brown JMB, Harji D

HER2 in Uterine Serous Carcinoma: Testing platforms and implications for targeted therapy.

Klc TR, Wu S, Wilhite AM, Jones NL, Powell MA, Olawaiye A, Girda E, Brown J, Puechl A, Ali-Fehmi R, Winer IS, Herzog TJ, Korn WM, Erickson BK

Type I interferon receptor signalling deficiency results in dysregulated innate immune responses to SARS-CoV-2 in mice.

Ogger PP, Garcia Martín M, Michalaki C, Zhou J, Brown JC, Du Y, Miah KM, Habib O, Hyde SC, Gill DR, Barclay WS, Johansson C

Economic Evaluation of the $35 Insulin Copay Cap Policy in Medicare and Its Implication for Future Interventions.

Shao H, Guan D, Fonseca V, Shi L, Basu A, Pop-Busui R, Ali MK, Brown J